Project | ScopeScope |
This project team will define best practices for ensuring that similar types of adverse events are considered together for purposes of safety analyses. This project will develop efficient standardised processes and analyses that can leverage new technologies. |
Project Leads | Emails | ||
---|---|---|---|
Mac Gordon, Johnson & Johnson | Mary Nilsson | nilsson_mary_e@lilly.com | |
Peg Fletcher, MedAssessment | peg.fletcher@medassessment | Greg Ball | gball@novavax.com |
Objectives & Deliverables | |||
White Paper | |||
Nicola Newton, PHUSE Project Assistant | Journal Article |
| ||||||
---|---|---|---|---|---|---|
New project for Q22022 | ||||||
Project Members | Organisation | |||||
Brian Panik | MedAssessment | |||||
Emily Goren | Seagen | |||||
Mac Gordon | Johnson & Jhonson | |||||
Nhi Beasley | FDA | |||||
Rebeka Revis | IQVIA | |||||
Scott Proestel | FDA | Vaishali Popat | FDA||||
Q1 2024 | ||||||
|
Objectives & Deliverables | Timelines |
---|---|
Complete White Paper final draft | Q2 2023 |